Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanus Rozsypal

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Current HIV Research|November 21, 2009
Acute appendicitis as a manifestation of the immune reconstitution inflammatory syndromeLadislav Machala, David Jilich, Hanus Rozsypal, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 31, 2005
[Prevalence of GBV-C/HGV (HGV) in HIV-infected patients and potential influence of co-infection on the course of the disease.]Viktor Aster, Jaroslav König, Marie Stanková, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|November 17, 2009
[Two types of CMV ocular complications in patients with HIV infection]Pavel Kozner, Hanus Rozsypal, Ladislav Machala, et al.
HIV Research & Clinical Practice|April 11, 2026
Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failureKrystof Sram, Hanus Rozsypal, Stanislav Sevela, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 30, 2008
[Proposals for guidelines for vaccination of adults infected with HIV-1 in the Czech Republic]David Jilich, Ladislav Machala, Hanus Rozsypal, et al.
Current HIV Research|August 13, 2013
Toxic shock syndrome and persistent immune activation in an HIV-positive patientMichal Holub, Simona Arientová, David Jilich, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|November 24, 2004
[CD38 antigen as a marker for immunological follow-up in HIV-positive patients]Michal Holub, Ondrej Beran, Ján Kalanin, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Prevalence and incidence of Toxoplasma infection in HIV-positive patients in the Czech RepublicPetr Kodym, Stepánka Hrdá, Ladislav Machala, et al.
HIV Research & Clinical Practice|January 29, 2026
Unmasking the impact of cytomegalovirus reactivation in people with advanced HIV disease with <i>Pneumocystis Jirovecii</i> pneumonia: does antiviral therapy change outcomes?Krystof Sram, David Jilich, Dan Vesely, et al.
Biomed Research International|August 7, 2015
The Effect of Latent Toxoplasma gondii Infection on the Immune Response in HIV-Infected PatientsOndrej Beran, Petr Kodym, Marek Maly, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Current HIV Research|November 21, 2009
Acute appendicitis as a manifestation of the immune reconstitution inflammatory syndromeLadislav Machala, David Jilich, Hanus Rozsypal, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 31, 2005
[Prevalence of GBV-C/HGV (HGV) in HIV-infected patients and potential influence of co-infection on the course of the disease.]Viktor Aster, Jaroslav König, Marie Stanková, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|November 17, 2009
[Two types of CMV ocular complications in patients with HIV infection]Pavel Kozner, Hanus Rozsypal, Ladislav Machala, et al.
HIV Research & Clinical Practice|April 11, 2026
Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failureKrystof Sram, Hanus Rozsypal, Stanislav Sevela, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 30, 2008
[Proposals for guidelines for vaccination of adults infected with HIV-1 in the Czech Republic]David Jilich, Ladislav Machala, Hanus Rozsypal, et al.
Current HIV Research|August 13, 2013
Toxic shock syndrome and persistent immune activation in an HIV-positive patientMichal Holub, Simona Arientová, David Jilich, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|November 24, 2004
[CD38 antigen as a marker for immunological follow-up in HIV-positive patients]Michal Holub, Ondrej Beran, Ján Kalanin, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Prevalence and incidence of Toxoplasma infection in HIV-positive patients in the Czech RepublicPetr Kodym, Stepánka Hrdá, Ladislav Machala, et al.
HIV Research & Clinical Practice|January 29, 2026
Unmasking the impact of cytomegalovirus reactivation in people with advanced HIV disease with <i>Pneumocystis Jirovecii</i> pneumonia: does antiviral therapy change outcomes?Krystof Sram, David Jilich, Dan Vesely, et al.
Biomed Research International|August 7, 2015
The Effect of Latent Toxoplasma gondii Infection on the Immune Response in HIV-Infected PatientsOndrej Beran, Petr Kodym, Marek Maly, et al.
Pageof 3